FOREFRONT ANALYTICS, LLC – CytomX Therapeutics, Inc. Transaction History
FOREFRONT ANALYTICS, LLC portfolio value:
$71,000
portfolio value
FOREFRONT ANALYTICS, LLC quarter portfolio value change:
-20.77%
quarter
CytomX Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +33.27% | 11.95K shares | 4K | $1.45 | 47.86K |
| Q2 2022 | share | Increase | +145.28% | 21.27K shares | 27K | $1.83 | 35.91K |
| Q1 2022 | share | Increase | +6.55% | 900 shares | -22K | $2.67 | 14.64K |
| Q4 2021 | share | Increase | +2.61% | 350 shares | -6K | $4.4 | 13.74K |
| Q3 2021 | share | Increase | 0.00% | 13.39K shares | 68K | $5.09 | 13.39K |